Sports Medicine

, Volume 1, Issue 2, pp 154–171 | Cite as

Endorphins and Exercise

  • Victoria J. Harber
  • John R. Sutton
Research Review

Summary

The endogenous opioids seem likely to be assigned a significant role in the integrated hormonal and metabolic response to exercise. This article reviews the present evidence on exercise and the endogenous opioids, and examines their involvement in a number of widely disparate physiological processes. In considering the role of individual opioid peptides, it is important to remember that many of the tools and techniques now used are still relatively crude.

Most studies have demonstrated that serum concentrations of endogenous opioids, in particular β-endorphin and β-lipotrophin, increase in response to both acute exercise and training programmes. Elevated serum β-endorphin concentrations induced by exercise have been linked to several psychological and physiological changes, including mood state changes and “exercise-induced euphoria”, altered pain perception, menstrual disturbances in female athletes, and the stress responses of numerous hormones (growth hormone, ACTH, prolactin, catecholamines and Cortisol). Many reports have described a role for the endorphin response as seen during exercise and have used the opioid receptor antagonist, naloxone, to investigate and verify the degree of involvement of the opioids. However, whether the observed increases in peripheral endorphin concentrations are sufficient to cause immediate mood changes, create menstrual cycle dysfunction or alter pain perception is still not resolved.

A relatively new implication for the endorphins and associated changes with exercise is in ventilatory regulation. A number of studies have suggested that endogenous opioids depress ventilation and may, therefore, play a role in ventilatory regulation by carbon dioxide, hypoxia and exercise. It may also be possible that during exercise, the perception of fatigue is modulated by an increase of endogenous opioids.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Akil, H.; Watson, S.J.; Berger, P.A. and Barchas, J.D.: Endorphins, β-LPH, and ACTH: Biochemical, pharmacological and anatomical studies. Advances in Biochemistry and Psycho-pharmacology 18: 125–139(1978).Google Scholar
  2. Ayres, J.; Rees, J.; Lee, T. and Cochrane, CM.: Intravenous naloxone in acute respiratory failure. British Medical Journal 284: 927–928 (1982).PubMedCrossRefGoogle Scholar
  3. Bahrke, M.S. and Morgan, W.P.: Anxiety reduction following exercise and meditation. Cognitive Therapy Research 2: 323–333(1978).CrossRefGoogle Scholar
  4. Baker, E.R.: Menstrual dysfunction and hormonal status in athletic women: A review. Fertility and Sterility 36: 691–696 (1981).PubMedGoogle Scholar
  5. Baker, E.R.; Mathur, R.S.; Kirk, R.F. and Williamson, H.O.: Female runners and secondary amenorrhea: Correlation with age, parity, mileage, and plasma hormonal and sex-hormonal binding globulin concentrations. Fertility and Sterility 36: 183–187(1981).PubMedGoogle Scholar
  6. Barta, A. and Yashpal, K.: Regional redistribution of β-EP in rat brain: The effect of stress. Progress in Neuro-Psychophar-macology 5: 595–598 (1981).CrossRefGoogle Scholar
  7. Berk, L.S.; Tan, S.A.; Anderson, C.L. and Reiss, G.: β-EP response to exercise in athletes and non-athletes. Medicine and Science in Sports and Exercise 13: 134 (1981).Google Scholar
  8. Blankstein, J.; Reyes, F.I.; Winter, J.S.D. and Faiman, C: Effects of naloxone upon prolactin and Cortisol in normal women. Proceedings of the Society for Experimental Biology and Medicine 164: 363–365(1980).PubMedGoogle Scholar
  9. Blankstein, J.; Reyes, F.I.; Winter, J.S.D. and Faiman, C: Endorphins and the regulation of the human menstrual cycle. Clinical Endocrinology (Oxford) 14: 287–294 (1981).CrossRefGoogle Scholar
  10. Bonen, A.; Belcastro, A.N.; Ling, W.Y. and Simpson, A.A.: Profiles of selected hormones during the menstrual cycle of teenage athletes. Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology 50: 545–551 (1981).Google Scholar
  11. Bonen, A.; Ling, W.Y.; Maclntyre, K.P.; Neil, R.; McGrail, J.C. and Belcastro, A.N.; Effects of exercise on the serum concentrations of FSH, LH, P and E2. European Journal of Applied Physiology 42: 15–23 (1979).CrossRefGoogle Scholar
  12. Bortz. W.M. II; Angevin, P.; Mefford, I.N.; Boarder, M.B.; Noyce, N. and Barchas, J.D.: Catecholamines, dopamine and endorphin levels during extreme exercise. New England Journal of Medicine 305: 466–467 (1981).PubMedGoogle Scholar
  13. Brands, B.; Thornhill, J.B.; Hirst, M. and Gowdey, C.W.: Suppression of food intake and body weight gain by naloxone in rats. Life Sciences 24: 1773–1778 (1979).PubMedCrossRefGoogle Scholar
  14. Bullen. B.A.; Skrinar, G.S.; Carr, D.B.; Gervino, E.V.; Reppert, S.U.; Dotson, C.O.; Beitins, I.Z. and McArthur, J.W.: Moderate endurance training effects on hormonal responses to serial exercise testing. Journal of Applied Physiology: Respiratory, Exercise and Environmental Physiology. In press (1984).Google Scholar
  15. Carr, D.B.; Bullen, B.A.; Skrinar, G.S.; Arnold, M.A.; Rosenblatt, M.; Beitins, I.Z.; Martin, J.B. and McArthur, J.W.: Physical conditioning facilitates the exercise-induced secretion of β-endorphin and β-lipotropin in women. New England Journal of Medicine 305: 560–563(1981).PubMedCrossRefGoogle Scholar
  16. Cohen, J.L.; Kim, C.S.; May Jr, P.B. and Ertel, N.H.: Exercise, body weight and amenorrhea in professional ballet dancers. Physician and Sportsmedicine 10: 92–101 (1982).Google Scholar
  17. Colt, E.W.D.; Wardlaw, S.L. and Frantz, A.G.: The effect of running on plasma β-endorphin. Life Sciences 28: 1637–1640 (1981).PubMedCrossRefGoogle Scholar
  18. Dale, E.; Gerlach, D.H. and Wilhite, A.L.: Menstrual dysfunction in distance runners. Obstetrics and Gynecology 54: 47–53 (1979).PubMedCrossRefGoogle Scholar
  19. Delitala, G.; Grossman, A. and Besser, G.M.: The modulation of opiate-induced changes in anterior pituitary function by a dopamine agonist and antagonist. Neuroendocrinology Letters 3: 147–152 (1981a).Google Scholar
  20. Delitala, G.; Grossman, A. and Besser, G.M.: Changes in pituitary hormone levels induced by met-enkephalin in man — the role of dopamine. Life Sciences 29: 1537–1544 (1981b).PubMedCrossRefGoogle Scholar
  21. del Pozo, E.; von Graffenried, B.; Brownell, J.; Derrer, F. and Marbach, P.: Endocrine effect of a methionine-enkephalin derivative (FK-33-824) in man. Hormonal Research 13: 90–97 (1980).CrossRefGoogle Scholar
  22. de Weid, D.; Bohus, B.; van Ree, J.M. and Urban, I.: Behavioral and electrophysiological effects of peptides related to lipotropin. Journal of Pharmacology and Experimental Therapy 204: 570–580(1978).Google Scholar
  23. Faiman, C.; Blankstein, J.; Reyes, F.I. and Winter, J.S.D.: Endorphins and the regulation of the human menstrual cycle. Fertility and Sterility 36: 267–268 (1981).Google Scholar
  24. Farrell, P.A.; Gates, W.K.; Morgan, W.P. and Maksud, M.G.: Increases in plasma β-EP and β-LPH immunoreactivity after treadmill running in humans. Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology 52: 1245–1249(1982).Google Scholar
  25. Farrell, P.A.; Gates, W.K.; Morgan, W.P. and Pent, C.B.: Plasma leucine enkephalin-like radioreceptor activity and tension-anxiety before and after competitive running; in Knuttgen, H.G.; Vogel, J. A. and Poortmans, J. (Eds) Biochemistry of Exercise (Human Kinetics Publishers, Champaign, Illinois 1983).Google Scholar
  26. Fears, W.B.; Yu, J.; Ferguson, E.; Glass, A.R. and Vigersky, R.: Mechanism of exercise-induced secondary amenorrhea. Proc. 65th mtg Endocrine Society, p.86 (1982).Google Scholar
  27. Feldman, M.; Kiser, R.S.; Unger, R.H. and Li, C.H.: β-EP and the endocrine pancreas: Studies in healthy and diabetic human beings. New England Journal of Medicine 308: 349–353 (1983).PubMedCrossRefGoogle Scholar
  28. Foley, K.M.; Kourides, I.A.; Inturrisi, C.E.; Kaiko, R.F.; Zaroulis, C.G.; Posner. J.B.: Houde, R.W. and Li, C.H.: β-Endorphin: Analgesic and hormonal effects in humans. Proceedings of the National Academy of Science of the U.S.A. 76: 5377–5381 (1979).CrossRefGoogle Scholar
  29. Fraioli, F; Moretti, C; Paolucci, D.; Alicicco, E.; Crescenzi, F. and Fortunio, G.: Physical exercise stimulates marked concomitant release of β-endorphin and ACTH in peripheral blood in man. Experientia 36: 987–989 (1980).PubMedCrossRefGoogle Scholar
  30. Frenk, H.; McCarty, B.L. and Lieberkind, J.C.: Different brain areas mediate the analgesic and epileptic properties of enkephalin. Science 200: 335–337 (1978).PubMedCrossRefGoogle Scholar
  31. Frisch, R.E.; Wyshak, G. and Vincent, L.: Delayed menarche and amenorrhea in ballet dancers. New England Journal of Medicine 303: 17–19(1980).PubMedCrossRefGoogle Scholar
  32. Gambert, S.R.; Garthwaite, T.L.; Pontzer, C.H.; Cook, E.E.; Tris-tani, F.E.; Duthie, E.H.; Martinson, D.R.; Hagen, T.C. and McCarty, D.J.: Running elevates plasma β-endorphin immunoreactivity and ACTH in untrained human subjects. Proceedings of the Society of Experimental Biology and Medicine 168: 1–4 (1981a).Google Scholar
  33. Gambert, S.R.; Hagen, T.C; Garthwaite, T.L.; Duthie Jr, E.H. and McCarty, D.J.: Exercise and the endogenous opioids. New England Journal of Medicine 305: 1590–1592 (1981b).CrossRefGoogle Scholar
  34. Goldstein, A.; Tachibana, S.; Lowney, L.I.; Hunkapiller, M. and Hood, L.: Dynorphin-(l–13), an extraordinarily potent opioid peptide. Proceedings of the National Academy of Science of the U.S.A. 76: 6666–6670 (1979).CrossRefGoogle Scholar
  35. Grevert. P. and Goldstein, A.: Effects of NAL on experimentally induced ischemic pain and on mood in human subjects. Proceedings of the National Academy of Science of the U.S.A. 74: 1291–1294(1977).CrossRefGoogle Scholar
  36. Grossman, A. and Besser, G.M.: Opiates control ACTH through a noradrenergic mechanism. Clinical Endocrinology (Oxford) 17: 287–290(1982).CrossRefGoogle Scholar
  37. Grossman, A.; Bouloux, P.; Price, P.; Drury, P.; Lam, K.; Alberti, K.; Turner, T.; Besser, G.M. and Sutton, J.R.: The role of opioid peptides in the hormonal responses to acute exercise in man. Clinical Science. (In press, 1984).Google Scholar
  38. Grossman, A.; Gaillard, R.C.; McCartney, P.; Rees, L.H. and Besser, G.M.: Opiate modulation of the pituitary-adrenal axis: Effects of stress and circadian rhythm. Clinical Endocrinology (Oxford) 17: 279–286 (1982a).CrossRefGoogle Scholar
  39. Grossman, A.; Moult, P.J.A.; McIntyre, H.; Evans, J.; Silverstone, T.; Rees, L.H. and Besser, G.M.: Opiate mediation of amenorrhea in hyperprolactinaemia and in weight-loss related amenorrhea. Clinical Endocrinology (Oxford) 17: 379–388 (1982b).CrossRefGoogle Scholar
  40. Grossman, A. and Rees, L.H.: The neuroendocrinology of opioid peptides. British Medical Bulletin 39: 83–88 (1983).PubMedGoogle Scholar
  41. Guillcmin, R.: Biochemical and physiological correlates of hypothalamic peptides. The new endocrinology of the neuron; in Reichlin, Baldessarini and Martin (Eds) The Hypothalamus, pp. 155–194 (Raven Press, New York 1978).Google Scholar
  42. Guillemin, R.T.; Varga, J.; Rossier, S.; Minick, N.; Ling, C; Rivier, W.; Vale, W. and Bloom, F.: β-Endorphin and adreno-corticotropin are secreted concomitantly by the pituitary gland. Science 197: 1367–1369(1977).PubMedCrossRefGoogle Scholar
  43. Haier, R.J.; Quaid, K. and Mills, J.S.C.: Naloxone alters pain perception after jogging. Psychiatric Research 5: 231–232 (1981).CrossRefGoogle Scholar
  44. Hartley, L.H.; Mason, J.W.; Hogan, R.P.; Jones, L.G.; Kotchen, T.A.; Mougey, E.H.; Wherry, F.E.; Pennington, L.L. and Ricketts, P.T.: Multiple hormonal responses to prolonged exercise in relation to physical training. Journal of Applied Physiology 33: 607–610(1972).PubMedGoogle Scholar
  45. Holaday, J.W.; Loh, H. and Li, C.H.: Unique behavioral effects of β-endorphin and their relationship to thermoregulation and hypothalamic function. Life Sciences 22: 1525–1536(1978).PubMedCrossRefGoogle Scholar
  46. Hughes, J.: Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine. Brain Research 88: 295–308(1975).PubMedCrossRefGoogle Scholar
  47. Hughes, J.; Smith, T.W; Kosterlitz, H.W.; Fothergill, L.A.; Morgan, B.A. and Morris, H.R.: Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 258: 577–579(1975).PubMedCrossRefGoogle Scholar
  48. Kosterlitz, H.W. and Hughes, J.: The opiate receptor; in Goldstein (Ed.) The Opiate Narcotics: Neurochemical Mechanisms in Analgesia and Dependence, pp.245–250 (Pergamon Press, New York 1975).Google Scholar
  49. Lemaire, I.; Tseng, R. and Lemaire, S.: Systemic administration of β-EP: Potent hypotensive effect involving a serotonergic pathway. Proceedings of the National Academy of Science of the U.S.A. 75: 6240–6242 (1978).CrossRefGoogle Scholar
  50. Li, C.H.: Lipotropin, a new active peptide from pituitary glands. Nature 201: 924(1964).PubMedCrossRefGoogle Scholar
  51. Li, C.H.: β-Endorphin: A pituitary peptide with potent morphinelike reactivity. Archives of Biochemistry and Biophysics 183: 592–604(1977).PubMedCrossRefGoogle Scholar
  52. Lundberg, J.M.; Hokfelt, T.; Fahrenkrug, J.; Nilsson, G. and Terenius, L.: Peptides in the cat carotid body (glomus caroticum): VIP-. enkephalin-, and substance P-like immunoreactivity. Acta Physiologica Scandinavica 107: 279–281 (1979).PubMedCrossRefGoogle Scholar
  53. Markoff, R.A.; Ryan, P. and Young, T.: Endorphins and mood changes in long-distance running. Medicine and Science in Sports and Exercise 14: 11–15 (1982).PubMedCrossRefGoogle Scholar
  54. Mayer, G.; Wessel, J. and Kobberling, J.: Failure of NAL to alter exercise-induced GH and PRL release in normal men. Clinical Endocrinology (Oxford) 13: 413–416 (1980).CrossRefGoogle Scholar
  55. McArthur, J.W.: Endorphins and exercise in females: Possible connection with reproductive dysfunction. Medicine and Science in Sports and Exercise. (In press, 1984).Google Scholar
  56. McArthur, J.W.; Bullen, B.A.; Beitins, I.Z.; Pagano, M.; Badger, T.M. and Klibanski, A.: Hypothalamic amenorrhea in runners of normal body composition. Endocrinology Research Communications 7: 13–25(1980).CrossRefGoogle Scholar
  57. McDonald, R.K.; Evans, F.T.; Weise, V.K. and Patrick, R.W.: Effect of morphine and naloxone on plasma hydrocortisone levels in man. Journal of Pharmacological Experimental Therapeutics 125: 241–247 (1959).Google Scholar
  58. McNair, D.M.; Lorr, M. and Droppleman, L.F.: Profile of Mood States Manual (Educational and Industrial Testing Service, San Diego 1971).Google Scholar
  59. McQueen, D.S.: Opioid interactions with respiratory and circulatory systems. British Medical Bulletin 39: 77–82 (1983).PubMedGoogle Scholar
  60. Meites, J.: Relation of endogenous opioid peptides to secretion of hormones. Federation Proceedings 39: 2531–2532 (1980).PubMedGoogle Scholar
  61. Meyerson, B.J. and Terenius, L.: β-EP and male sexual behaviour. European Journal of Pharmacology 42: 191–192 (1977).PubMedCrossRefGoogle Scholar
  62. Moretti, C.; Fabbri, A.; Gnessi, L; Cappa, M.; Calzolari, A.; Fraioli, F.; Grossman, A. and Besser, G.M.: NAL inhibits exercise-induced release of PRL and GH in athletes. Clinical Endocrinology (Oxford) 18: 135–138 (1983).CrossRefGoogle Scholar
  63. Morgan, W.P.: Exercise-induced euphoria: Fact or fancy? Medicine and Science in Sports and Exercise. (In press, 1984).Google Scholar
  64. Morley, J.E.: The neuroendocrine control of appetite: The role of endogenous opiates, cholecystokinin, TRH, gamma-amino butyric acid and the diazepam receptor. Life Sciences 27: 335–368 (1980).Google Scholar
  65. Morley, J.E.: The endocrinology of the opiates and opioid peptides. Metabolism 30: 195–209 (1981).PubMedCrossRefGoogle Scholar
  66. Morley, J.E. and Levine, A.S.: Stress-induced eating is mediated through endogenous opiates. Science 209: 1259–1261 (1980).PubMedCrossRefGoogle Scholar
  67. Moss, I.R. and Friedman, E.: β-EP: Effects on respiratory regulation. Life Sciences 23: 1271–1276 (1978).PubMedCrossRefGoogle Scholar
  68. Nakao, K.; Nakai, Y.; Oki, S.; Matsubara, S.; Konishi, T.; Nishitani, H. and Imura, H.: Immunoreactive β-endorphin in human cerebrospinal fluid. Journal of Endocrinology and Metabolism 50: 230–233 (1980).CrossRefGoogle Scholar
  69. Oyama, T.; Jin, T.; Yamaya, R.; Ling, N. and Guillemin, R.: Profound analgesic effects of β-endorphin in man. Lancet 1: 122–124 (1980).PubMedCrossRefGoogle Scholar
  70. Paton, W.D.M.: The action of morphine and related substances on contraction and on acetylcholine output of coaxially stimulated guinea pig ileum. British Journal of Pharmacology and Chemotherapy 12: 119–127 (1957).PubMedGoogle Scholar
  71. Prior, J.C.; Ho Yuen, B.; Jensen, L.; Brownlie, L. and Haggis, H.: Controlled study of pituitary and gonadal stimulation during control and exercise menstrual cycles in normal women. Clinical and Investigative Medicine 4: 16B (1981).Google Scholar
  72. Quigley, M.E. and Yen, S.S.: The role of endogenous opiates on LH secretion during the menstrual cycle. Journal of Clinical Endocrinology and Metabolism 51: 179–181 (1980).PubMedCrossRefGoogle Scholar
  73. Reid, R.L.; Hoff, J.D.; Yen, S.S.C. and Li, C.H.: Effects of exogenous β-endorphin on pituitary hormone secretion and its disappearance rate in normal human subjects. Journal of Clinical Endocrinology and Metabolism 52: 1179–1184 (1981).PubMedCrossRefGoogle Scholar
  74. Reith, P.; Byrd, P.; Silver, B.; Kyner, J. and Thomas, T.R.: Pre-menarchial hormonal pattern in lean athletic women with secondary amenorrhea. Medicine and Science in Sports and Exercise 14: 145 (1982).Google Scholar
  75. Rennie, M.J.; Jennett, S. and Johnson, R.H.: The metabolic effects of strenuous exercise: A comparison between untrained subjects and racing cyclists. Quarterly Journal of Experimental Physiology 59: 201–212 (1974).Google Scholar
  76. Ropert, J.F.; Quigley, M.E. and Yen, S.S.C.: Endogenous opiates modulate pulsatile LH release in humans. Journal of Clinical Endocrinology and Metabolism 52: 583–585 (1981).PubMedCrossRefGoogle Scholar
  77. Santen, R.J.; Sofsky, J.; Bilic, N. and Lippert, R.: Mechanism of action of narcotics in the production of menstrual dysfunction in women. Fertility and Sterility 26: 538–548 (1975).PubMedGoogle Scholar
  78. Schaumann, W.: Inhibition by morphine of the release of acetylcholine from the intestine of the guinea pig. British Journal of Pharmacology and Chemotherapy 12: 115–118 (1957).PubMedGoogle Scholar
  79. Schwartz, B.; Cumming, D.C.; Riordan, E.; Selye, M.; Yen, S.S.C. and Rebar, R.W.: Exercise-associated amenorrhea: A distinct entity? American Journal of Obstetrics and Gynecology 141: 662–670 (1981).PubMedGoogle Scholar
  80. Shangold, M.; Freeman, R.; Thysen, B. and Gatz, M.: The relationship between long-distance running, plasma P and luteal phase length. Fertility and Sterility 31: 130–133 (1979).PubMedGoogle Scholar
  81. Simantov, R.; Goodman, R.; Aposhian, D. and Snyder, S.H.: Phylogenetic distribution of a morphine-like peptide enkephalin. Brain Research 111: 204–211 (1976).PubMedCrossRefGoogle Scholar
  82. Spiler, I.J. and Molitch, M.E.: Lack of modulation of pituitary hormone stress response by neural pathways involving opiate receptors. Journal of Clinical Endocrinology 50: 516–520 (1980).CrossRefGoogle Scholar
  83. Stephen, G.W.; Cooper, L.V. and Harvey, D.: The effect of narcotic-antagonist drugs in the newborn rabbit. British Journal of Anaesthesia 48: 635–637 (1976).PubMedCrossRefGoogle Scholar
  84. Stubbs, W.A., Jones, A.; Edwards, C.R.W.; Delitala, G.; Jeffcoate, W.J.; Ratter, S.J.; Besser, G.M.; Bloom, S.R. and Alberti, K.G.M.M.: Hormonal and metabolic responses to an enkephalin analogue in normal man. Lancet 2: 1225–1227 (1978).PubMedCrossRefGoogle Scholar
  85. Sutton, J.R.: Endorphins and the physiological and metabolic responses to exercise. Medicine and Science in Sports and Exercise. (In press, 1984).Google Scholar
  86. Sutton, J.R.; Brown, G.M.; Keane, P.; Walker, W.H.C.; Jones, N.L.; Rosenbloom, D. and Besser, G.M.: The role of endorphins in the hormonal and psychological responses to exercise. International Journal of Sports Medicine 2: 19 (1982).Google Scholar
  87. Sutton, J.R. and Jones, N.L.: Control of pulmonary ventilation during exercise and mediators in the blood: CO: and hydrogen ion. Medicine and Science in Sports 11: 198–203 (1979).PubMedGoogle Scholar
  88. Sutton, J.R.; Young, J.D.; Lazarus, L.; Hickie, J.B. and Maksvytis, J.: The hormonal response to physical exercise. Australasian Annals of Medicine 18: 84–90 (1969).PubMedGoogle Scholar
  89. Terenius, L. and Wahlstrom, A.: Inhibitors of narcotic receptor binding in brain extracts and cerebrospinal fluid. Acta Pharmacologica et Toxicologica 35 (Suppl. 87): 55 (1974).Google Scholar
  90. Terjung, R.: Endocrine response to exercise; in Hutton (Ed.) Exercise and Sports Sciences Reviews 7: 153–180 (Franklin Institute Press, Philadelphia 1979).Google Scholar
  91. Tharp, G.D.: The role of glucocorticoids in exercise. Medicine and Science in Sports 7: 6–11 (1975).PubMedGoogle Scholar
  92. Tolis, G.; Hickey, J. and Guyda, H.: Effects of morphine, Cortisol, PRL and TSH in man. Journal of Clinical Endocrinology and Metabolism 41: 797–800 (1975).PubMedCrossRefGoogle Scholar
  93. Vale, W.; Spiess, J.; Rivier, C. and Rivier, J.: Characterization of a 42-residuc ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science 213: 1394–1397 (1981).PubMedCrossRefGoogle Scholar
  94. Volavka, J.; Bauman, J.; Pevnick, J.; Reker, D.; James, B. and Cho, D.: Short-term hormonal effects of NAL in man. Psychneuroendocrinology 5: 225–234 (1980).CrossRefGoogle Scholar
  95. Volavka, J.; Cho, D.; Mallya, A. and Bauman, J.: Naloxone increases ACTH and Cortisol levels in man. New England Journal of Medicine 300: 1056–1057 (1979).PubMedGoogle Scholar
  96. Von Graffenried, B.; del Pozo, E.; Roubicek, J.; Krebs, E.; Poldinger, W.; Burmeister, P. and Kerp, L.: Effects of the synthetic analogue FK 33-824 in man. Nature 272: 729–730 (1978).CrossRefGoogle Scholar
  97. Wahren, J.: Metabolic adaptation to physical exercise in man; in DeGroot et al. (Eds) Endocrinology, pp. 1911–1926 (Grune and Stratton, New York 1979).Google Scholar
  98. Warren, M.P.: The effects of exercise on pubertal progression and reproductive function in girls. Journal of Clinical Endocrinology and Metabolism 51: 1150–1156 (1980).PubMedCrossRefGoogle Scholar
  99. Wehrenberg, W.B.; Wardlaw, S.L.; Frantz, A.G. and Ferin, M.: β-Endorphin in hypophyseal portal blood: Variations throughout the menstrual cycle. Endocrinology 111: 879–881 (1982).PubMedCrossRefGoogle Scholar
  100. Wharton, J.; Polak, J.M.; Pearse, A.G.E.; McGregor, G.P.; Bryant, M.G.; Bloom, S.R.; Emson, P.C.; Bisgard, G.E. and Will, J.A.: Enkephalin-, VIP-, and substance P-like immunoreactivity in the carotid body. Nature 284: 269–271 (1980).PubMedCrossRefGoogle Scholar
  101. Wildt, L.; Niesert, S.; Wesner, G. and Layendecker, G.: Effects of naloxone on LH, FSH and prolactin secretion in hypothalamic amenorrhea. Acta Endocrinologica 97 (Suppl. 243): 52 (1981).Google Scholar
  102. Yates, A.; Leehey, K. and Shisslak, C.M.: Running — an analogue of anorexia? New England Journal of Medicine 308: 251–255 (1983).PubMedCrossRefGoogle Scholar

Copyright information

© ADIS Press Limited 1984

Authors and Affiliations

  • Victoria J. Harber
    • 1
  • John R. Sutton
    • 1
  1. 1.Department of MedicineMcMaster UniversityHamiltonCanada

Personalised recommendations